Secura Bio
Secura Bio, headquartered in Las Vegas, Nevada, with an office in Dublin, Ireland, develops and commercializes innovative medicines for serious illnesses, including COPIKTRA® for lymphomas.
Headquarters and Locations
Secura Bio is headquartered in Las Vegas, Nevada, with an additional office located in Dublin, Ireland. This geographical presence allows the company to oversee its operations and foster international collaborations effectively. The choice of locations reflects strategic positioning for both market reach and ease of conducting global clinical trials.
Innovative Medicines and Life-Changing Products
Secura Bio focuses on developing and commercializing innovative medicines and life-changing products for patients dealing with serious illnesses. The company's portfolio aims at providing solutions for critical health conditions, ensuring that patients receive the most advanced and effective treatments available.
Patient Support Program: Secura Care
Secura Care is a patient support program offered by Secura Bio. This program provides assistance with insurance verification, co-pay, and reimbursement resources. Secura Care is designed to help patients navigate the complexities of accessing their medications, ensuring they receive the support and resources needed throughout their treatment journey.
COPIKTRA® for Lymphoma Treatment
Secura Bio provides COPIKTRA® for the treatment of various lymphomas. The company offers dedicated information sites for both patients and physicians, ensuring that all stakeholders have access to comprehensive and accurate information regarding the medication, its usage, and its benefits. This approach aims to facilitate effective disease management and improve patient outcomes.
Clinical Trials and Research
Secura Bio conducts several clinical trials, including studies on Duvelisib for the treatment of Peripheral T-Cell Lymphoma and Indolent Non-Hodgkin Lymphoma. These trials are crucial for advancing the understanding and treatment of these conditions, contributing to the broader medical community's efforts to develop more effective therapeutic options for patients in need.